Skip to content
ppharmaranks
Menu
Class IIIOngoing

Lidocaine Wound Gel (Benzalkonium Chloride recall

FDA recall D-0509-2026 · initiated Apr 7, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated May 6, 2026How we research

Water-Jel Technologies, LLC recalled Lidocaine Wound Gel (Benzalkonium Chloride in Apr 2026 — an FDA Class III recall (D-0509-2026) because Failed PH Specifications.

Unlikely to cause harm but violates FDA labeling or manufacturing regulations.

Why it was recalled

Failed PH Specifications

The manufacturing process itself

The FDA found the process itself out of compliance, usually before any defective product was identified.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lots: A5014, A5018, A5019

Quantity recalled: 31,488 tubes

Details

Product
Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS PHarmacy, INc., One CVS Drive, Woonsocket, RI 02895. NDC 59898-950
Recalling company
Water-Jel Technologies, LLC
Classification
Class III
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Apr 7, 2026
FDA report date
May 6, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Lidocaine Wound Gel (Benzalkonium Chloride recalled?
Water-Jel Technologies, LLC recalled Lidocaine Wound Gel (Benzalkonium Chloride in Apr 2026 — an FDA Class III recall (D-0509-2026) because Failed PH Specifications. Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
Why was Lidocaine Wound Gel (Benzalkonium Chloride recalled?
Per the FDA enforcement record, the reason for recall D-0509-2026 was: Failed PH Specifications
Is a recalled Lidocaine Wound Gel (Benzalkonium Chloride dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Unlikely to cause harm but violates FDA labeling or manufacturing regulations. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Lidocaine Wound Gel (Benzalkonium Chloride are affected?
Distributed: Nationwide in the USA. The recall covers these lots — Lots: A5014, A5018, A5019. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0509-2026.

Source: openFDA Drug Enforcement record D-0509-2026

← All drug recalls